Nema Health Secures $14.5 Million to Expand Virtual PTSD Treatment

Deal News | Jan 08, 2025 | .406 Ventures Management LP

Nema Health, a clinician and survivor-led organization, has successfully raised $14.5 million in a Series A funding round to expand its virtual PTSD treatment services. The company's innovative approach is based on Cognitive Processing Therapy, which has proven to provide rapid relief and significant improvement for PTSD patients. With plans to extend its reach beyond the current eight states, including California, Florida, and New York, Nema Health aims to offer affordable and accessible care through partnerships with national and regional health insurers. As highlighted by Dr. Sofia Noori, Nema's co-founder and CEO, the company is committed to helping trauma survivors rebuild their lives. The backing by .406 Ventures will further support Nema in enhancing its offerings and solidifying its market position.

Sectors

  • Healthcare
  • Health Technology
  • Venture Capital

Geography

  • United States – Nema Health operates in the United States and is expanding its PTSD treatment services across several states.

Industry

  • Healthcare – The article is focused on Nema Health's efforts in providing PTSD treatment, a significant part of the healthcare industry.
  • Health Technology – Nema Health offers virtual PTSD treatment using innovative techniques, situating it within the health tech sector.
  • Venture Capital – The article discusses .406 Ventures' investment in Nema Health, highlighting the role of venture capital in funding healthcare innovations.

Financials

  • $14.5 Million – The amount raised by Nema Health in Series A funding to expand its services.

Participants

NameRoleTypeDescription
Nema HealthTarget CompanyCompanyA clinician and survivor-led organization providing virtual PTSD treatment.
.406 Ventures Management LPInvestorCompanyA private equity firm investing in Nema Health's Series A funding round.
Dr. Sofia NooriCo-founder and CEOPersonCo-founder and CEO of Nema Health, emphasizing the mission to aid trauma survivors.
Dr. Julian HarrisOperating PartnerPersonOperating Partner at Deerfield, commenting on PTSD treatment innovation.